ESG Report

Overview

The report documents Bristol Myers Squibb's 2023 ESG performance across patient access, scientific innovation, workforce inclusion, ethical business and environmental stewardship. It highlights a first TCFD report, submission of near-term and net-zero targets to SBTi, and a 2050 net-zero goal covering Scopes 1, 2 and 3. Environmental tables report 2023 Scope 1 emissions of 208,535 MT CO2e, market-based Scope 2 of 158,447 MT CO2e, Scope 3 of 1,750,947 MT CO2e, and 11,479 metric tons of waste. The report also includes GRI and SASB indices and an Apex limited assurance statement.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2023
Period: 1 January 2023 – 31 December 2023
Language: English
Pages
File size
Restatement: Disclosed

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level
SBTi status

Materiality

Assessment
Basis
Matrix

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services